282 related articles for article (PubMed ID: 31987921)
1. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.
Kuo CL; Chou HY; Chiu YC; Cheng AN; Fan CC; Chang YN; Chen CH; Jiang SS; Chen NJ; Lee AY
Cancer Lett; 2020 Apr; 474():138-150. PubMed ID: 31987921
[TBL] [Abstract][Full Text] [Related]
2. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles.
Cheng AN; Cheng LC; Kuo CL; Lo YK; Chou HY; Chen CH; Wang YH; Chuang TH; Cheng SJ; Lee AY
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268351
[TBL] [Abstract][Full Text] [Related]
4. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Lon Protease and Cancer.
Lu B
Adv Exp Med Biol; 2017; 1038():173-182. PubMed ID: 29178076
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells.
Gibellini L; Pinti M; Bartolomeo R; De Biasi S; Cormio A; Musicco C; Carnevale G; Pecorini S; Nasi M; De Pol A; Cossarizza A
Oncotarget; 2015 Sep; 6(28):25466-83. PubMed ID: 26314956
[TBL] [Abstract][Full Text] [Related]
7. FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis.
Chattaragada MS; Riganti C; Sassoe M; Principe M; Santamorena MM; Roux C; Curcio C; Evangelista A; Allavena P; Salvia R; Rusev B; Scarpa A; Cappello P; Novelli F
Oncogene; 2018 Feb; 37(6):697-709. PubMed ID: 29059164
[TBL] [Abstract][Full Text] [Related]
8. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
9. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
10. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Kuo CL; Ponneri Babuharisankar A; Lin YC; Lien HW; Lo YK; Chou HY; Tangeda V; Cheng LC; Cheng AN; Lee AY
J Biomed Sci; 2022 Sep; 29(1):74. PubMed ID: 36154922
[TBL] [Abstract][Full Text] [Related]
14. Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer
Sang S; Zhang C; Shan J
Cancer Biother Radiopharm; 2019 Aug; 34(6):380-387. PubMed ID: 30916574
[No Abstract] [Full Text] [Related]
15. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
16. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
[TBL] [Abstract][Full Text] [Related]
18. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species.
Cheng CW; Kuo CY; Fan CC; Fang WC; Jiang SS; Lo YK; Wang TY; Kao MC; Lee AY
Cell Death Dis; 2013 Jun; 4(6):e681. PubMed ID: 23788038
[TBL] [Abstract][Full Text] [Related]
20. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
